Page 109 - Mutation News Today

Focus on gene vaccines in fight against COVID-19 But we will certainly also look back on a time when a huge medical advancement was achieved in a very short time — with mRNA, a whole new vaccine concept is being developed. It should be noted that "We now know much, much more about this virus, how it develops, what makes it tick, and we can now produce an adequate vaccine much more quickly than we could six to nine months ago," said Eichler. In other words, we are far from starting from sq...

It remains unclear whether Kent mutation is as lethal as main coronavirus, says leading scientist.

To sell the 1.5 million acquired doses of the vaccine; secure the unauthorised vaccine from J&J for inoculation

Researchers at NYU Grossman School of Medicine in New York have conducted a study demonstrating the effectiveness of the Pfizer-BioNtech BNT162b2 vaccine against recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

A team of scientists from the United States has recently explored the prevalence and transmission dynamics of the B.1.1.7 variant (UK variant) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States. The study reveals that because of 35-45% increased transmissibility, B.1.1.7 may soon become the US's dominant variant. The study is currently available on the medRxiv* preprint server.

For the study, published in the journal MedRxiv, the researchers have analysed half a million coronavirus tests and hundreds of genomes of the B.1.1.7 variant of Covid-19

The number of Covid-19 symptoms continues to increase as the coronavirus is mutating. Heres a look at what these symptoms are.

WHO’s Strategic Advisory Group of Experts on Immunisation reported limited effectiveness of the Oxford-AstraZeneca vaccine (named Covishield in India), against the South African strain

The New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) has named one additional SARS-CoV-2 Variant Under Investigation and one...

Use at least 8 characters, an uppercase and a lowercase letter, and a number or symbol. Please ensure your password has at least 8 characters, an uppercase and a lowercase letter, and a number or symbol. By clicking Create Account and Subscribe you agree to us creating an account for you and subscribing you to our newsletter in accordance with our Privacy Policy and Legal Notice. Emails, which may be sent daily or less frequently, may include marketing elements. We will not share your email add...